Evidence map›Paper›PMID 34732401›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2021

Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin's Lymphoma Survivors.

Krista Ocier, Sarah Abdelaziz, Seungmin Kim, Kerry Rowe, John Snyder, Vikrant G Deshmukh, Michael Newman, Alison Fraser, Ken R Smith, Christina A Porucznik and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Survivorship preparedness and activation among survivors of lymphoma.Journal of cancer survivorship : research and practice · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Krista OcierDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0002-5822-3552
Sarah AbdelazizHuntsman Cancer Institute, Salt Lake City, Utah.
Seungmin KimDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0003-0291-4845
Kerry RoweIntermountain Healthcare, Salt Lake City, Utah.
John SnyderIntermountain Healthcare, Salt Lake City, Utah.
Vikrant G DeshmukhUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Michael NewmanUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Alison FraserPedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0003-1681-698X
Ken R SmithPedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0003-0682-3705
Christina A PorucznikDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0003-1973-2917
Kimberley ShoafDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0001-6754-2216
Joseph B StanfordDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Catherine J LeeDivision of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Mia HashibeDivision of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah. mia.hashibe@utah.edu.
University of Utah · USHuntsman Cancer Institute · USUtah Department of Health · USVA Salt Lake City Healthcare System · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based CohortR01CA244326 · NCI · UNIVERSITY OF UTAH · PI CAMP, NICOLA J., HASHIBE, MIA · 2020 to 2024
$2.4M
Population-based Cohort of Endometrial Cancer Survivors in UtahR21CA185811 · NCI · UNIVERSITY OF UTAH · PI HASHIBE, MIA · 2015 to 2016
$356k
Epidemiology of testicular cancer in the Utah populationR03CA159357 · NCI · UNIVERSITY OF UTAH · PI HASHIBE, MIA · 2011 to 2012
$150k
NCATS NIH HHS UL1 TR002538NCI NIH HHS HHSN261201100016INCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS P30 CA042014NCI NIH HHS R01 CA244326NCI NIH HHS R03 CA159357NCI NIH HHS R21 CA185811
6 · The paper itself

Abstract

backgroundYounger cancer survivors may develop age-related diseases due to the cancer treatment that they undergo. The aim of this population-based study is to estimate incidence of age-related diseases besides cardiovascular disease among younger versus older B-cell non-Hodgkin's lymphoma (B-NHL) survivors compared with their respective general population cohorts.

methodsSurvivors of B-NHL were diagnosed between 1997 and 2015 from the Utah Cancer Registry. Using the Utah Population Database, up to 5 cancer-free individuals from the general population were matched with a B-NHL survivor on sex, birth year, and state of birth. Hazard ratios (HR) for age-related disease outcomes, which were identified from medical records and statewide health care facility data, were estimated using Cox Proportional Hazards models for B-NHL survivors diagnosed at <65 years versus ≥65 years at least 5 years since B-NHL diagnosis.

resultsComparing 2,129 B-NHL survivors with 8,969 individuals from the general population, younger B-NHL survivors had higher relative risks of acute renal failure [HR, 2.24; 99% confidence interval (CI), 1.48-3.39;

conclusionYounger B-NHL survivors had higher relative risks of acute renal failure, pneumonia, and nutritional deficiencies than older B-NHL survivors compared with their respective general population cohorts, ≥5 years after cancer diagnosis.

Indexed as

AdultAgedAged, 80 and overAgingCancer SurvivorsChronic DiseaseFemaleHumansLymphoma, B-CellMaleMiddle AgedOutcome Assessment, Health CareProportional Hazards ModelsRetrospective StudiesRisk Assessment

Identifiers

PMID34732401
PMCPMC9894530
OpenAlexW3209008347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.